Literature DB >> 11249116

A new inhibitor design strategy for carboxypeptidase A as exemplified by N-(2-chloroethyl)-N-methylphenylalanine.

J D Park1, K J Lee, D H Kim.   

Abstract

N-(2-Chloroethyl)-N-methylphenylalanine was designed and synthesized in an optically active form as a novel class of mechanism-based inactivator for carboxypeptidase A (CPA). It was anticipated that the chloroethylamino moiety of the CPA bound inhibitor undergoes an intramolecular SN2 reaction to generate a chemically reactive species (an aziridinium ion) which is expectedly subjected to a nucleophilic attack by the carboxylate of Glu-270, leading to covalent modification of the carboxylate. The irreversible nature of the inhibition of CPA by the inhibitor was supported by the kinetic data: the enzyme lost its enzymic activity in a time-dependent manner in the presence of the inhibitor and the inactivated CPA failed to regain the activity upon dialysis. Interestingly, the (R)-isomer that belongs to the D-series was more potent than its enantiomer.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11249116     DOI: 10.1016/s0968-0896(00)00239-x

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  2 in total

1.  Interference of the noradrenergic neurotoxin DSP4 with neuronal and nonneuronal monoamine transporters.

Authors:  Birger Wenge; Heinz Bönisch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2009-10-17       Impact factor: 3.000

2.  Design, Synthesis and Evaluation of 2,5-Diketopiperazines as Inhibitors of the MDM2-p53 Interaction.

Authors:  Mariell Pettersson; Maria Quant; Jaeki Min; Luigi Iconaru; Richard W Kriwacki; M Brett Waddell; R Kiplin Guy; Kristina Luthman; Morten Grøtli
Journal:  PLoS One       Date:  2015-10-01       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.